| Biotechnology Industry | Healthcare Sector | Mr. Gyu-Beom Han CEO | KOSDAQ Exchange | KR7085660009 ISIN |
| KR Country | 278 Employees | - Last Dividend | 2 Jun 2014 Last Split | 27 Dec 2005 IPO Date |
Chabiotech Co.,Ltd., headquartered in Seoul, South Korea, is a pioneering bio company that specializes in the field of cell and gene therapy, focusing primarily on stem and immune cells. Founded in 2002, the company has established itself on both a national and international scale, dedicating its research and services to the development of innovative treatments for incurable diseases. Chabiotech extends its expertise in regenerative medicine, alongside offering comprehensive medical wellness programs. Furthermore, it equips its clients with advanced IT systems, consulting services for the Chaum model, maternal-centered genome testing, and personalized healthcare solutions, emphasizing its role in advancing the biotechnological and healthcare industries.
Chabiotech Co.,Ltd. offers a wide array of products and services designed to address the complex needs of its customers: